<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-vaccines-08-00115">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Franceschi</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Parker</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Jacca</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Crump</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Doronin</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Hembrador</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Pompilio</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Tebaldi</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Estep</surname>
    <given-names>R.D.</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>S.W.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>BoHV-4-based vector single heterologous antigen delivery protects stat 1 (-/-) mice from monkeypoxvirus lethal challenge</article-title>
  <source>PLoS Negl. Trop. Dis.</source>
  <year>2015</year>
  <volume>9</volume>
  <elocation-id>e0003850</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pntd.0003850</pub-id>
  <pub-id pub-id-type="pmid">26086739</pub-id>
 </element-citation>
</ref>
